LSBPW

LakeShore Biopharma Warrants
LSBPW

Delisted

LSBPW was delisted on the 19th of September, 2025.

Back to rankings

2 hedge funds and large institutions have $32 invested in LakeShore Biopharma Warrants in 2025 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 16 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

less ownership

Funds ownership: →

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

less funds holding in top 10

Funds holding in top 10: →

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 16

Holders
2
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter

Top Sellers

1
-$132K
2
-$42K
3
-$41.8K
4
Jane Street
Jane Street
New York
-$19.9K
5
FC
Finepoint Capital
Massachusetts
-$19.6K
Name Holding Trade Value Shares
Change 		Change in
Stake
HIM
1
HGC Investment Management
Ontario, Canada
$25
AA
2
Ancora Advisors
Ohio
$7
LP
3
LMR Partners
United Kingdom
–
Toronto Dominion Bank
4
Toronto Dominion Bank
Ontario, Canada
–
VAM
5
Valliance Asset Management
Hong Kong
–
Jane Street
6
Jane Street
New York
–
FC
7
Finepoint Capital
Massachusetts
–
BCL
8
Bracebridge Capital LLC
Massachusetts
–
Calamos Advisors
9
Calamos Advisors
Illinois
–
QGA
10
Q Global Advisors
Texas
–
AC
11
Athos Capital
Hong Kong
–
WA
12
Whitebox Advisors
Minnesota
–
TSS
13
Two Sigma Securities
New York
–
D.E. Shaw & Co
14
D.E. Shaw & Co
New York
–
SCM
15
Saba Capital Management
New York
–
Walleye Capital
16
Walleye Capital
New York
–
CF
17
Cantor Fitzgerald
New York
–
CS
18
Clear Street
New York
–